MLL Capital’s investment strategy is based on the deep belief that U.S. demographics support health care commercial real estate investment. The oldest portions of our population are growing at a rate that is 4 times the national average and they are consuming health care services at an ever-increasing rate. Continued growth in life expectancies are projected to compound this positive demand impact.
These long-term demographic characteristics combined with favorable demand and supply characteristics create superior risk-adjusted returns within both the medical office and lab sectors. Further, the confluence of capital, growing consumer demand and scientific advancement is causing both sectors to grow and appreciate more rapidly than many other commercial real estate sectors.
MLL Capital invests in medical office, lab and life science real estate on a national basis in the 36 largest MSAs. The firm invests across the risk spectrum, including core, core-plus and value-add real estate investments. Typically, the firm seeks investments where it can create value through strategic capital investment, detailed repositioning and redevelopment plans with a strong focus on targeted leasing.
National: 35 largest primary, secondary and tertiary MSAs
Value-add, Core-Plus and Core
Prefer on-campus or campus-adjacent but will buy off-campus with hospital / health system anchor tenancy
Boston, San Francisco, San Diego, Seattle & Washington D.C.
Value-Add, Core-Plus and Core